These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19393469)

  • 1. Statin effects in CKD: is there a "point of no return"?
    Wanner C
    Am J Kidney Dis; 2009 May; 53(5):723-5. PubMed ID: 19393469
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 3. JUPITER "moderate CKD" subgroup is not truly "moderate" chronic kidney disease.
    Roberts MA; Hare DL
    J Am Coll Cardiol; 2010 Aug; 56(6):528; author reply 530. PubMed ID: 20670769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 5. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for new indications for statins?
    Banach M; Mikhailidis DP; Kjeldsen SE; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS1-5. PubMed ID: 19946240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of dyslipoproteinemia in chronic renal failure].
    Krane V; Wanner C
    MMW Fortschr Med; 2006 Apr; 148(14):34-7. PubMed ID: 16669278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
    Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin in patients undergoing hemodialysis.
    de Oliveira JM
    N Engl J Med; 2009 Jul; 361(1):93-4; author reply 94-5. PubMed ID: 19579278
    [No Abstract]   [Full Text] [Related]  

  • 11. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins in patients with chronic kidney disease: why, who and when?
    Gluba A; Rysz J; Banach M
    Expert Opin Pharmacother; 2010 Nov; 11(16):2665-74. PubMed ID: 20977401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering cholesterol: is there a limit?
    Harv Mens Health Watch; 2007 May; 11(10):5-6, 8. PubMed ID: 17514824
    [No Abstract]   [Full Text] [Related]  

  • 14. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 15. New hope for chronic kidney disease patients after the JUPITER trial: myth or reality?
    Kassimatis TI; Goldsmith DJ
    J Am Coll Cardiol; 2010 Aug; 56(6):529. PubMed ID: 20670770
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin power.
    Diabetes Forecast; 2008 Apr; 61(4):28. PubMed ID: 18478640
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin therapy in patients with chronic kidney disease: to use or not to use.
    Steinmetz OM; Panzer U; Stahl RA; Wenzel UO
    Eur J Clin Invest; 2006 Aug; 36(8):519-27. PubMed ID: 16893373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use prolongs patient survival after renal transplantation.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2008 Nov; 19(11):2037-40. PubMed ID: 18842988
    [No Abstract]   [Full Text] [Related]  

  • 19. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.